-
Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin, Dermavant Sciences, Cara Therapeutics, Pfizer, Arena Pharmaceuticals
02 Jul 2024 17:00 GMT
New York, USA, July 02, 2024 (GLOBE NEWSWIRE) -- Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin, Dermavant Sciences, Cara Therapeutics, Pfizer, Arena …
-
Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli Lilly and Company, Merck Sharp & Dohme LLC, T
02 May 2024 17:00 GMT
New York, USA, May 02, 2024 (GLOBE NEWSWIRE) -- Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli Lilly and …
-
Fabry Disease Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight
10 Jun 2025 17:00 GMT
New York, USA, June 10, 2025 (GLOBE NEWSWIRE) -- Fabry Disease Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight The Fabry disease market is growing due to rising prevalence and better diagnostics. While ERTs and GALAFOLD dominate, …
-
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Arena Pharmaceuticals Inc. Buyout
14 Dec 2021 16:38 GMT
… . announces that it is investigating Arena Pharmaceuticals Inc. ("Arena") (NASDAQ … .rl-legal.com/cases-arena-pharmaceuticals-inc.
You may also contact … corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee …
-
ARENA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ARNA and Encourages Investors to Contact the Firm
13 Dec 2021 19:33 GMT
… the officers or directors of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) breached their … visit www.bespc.com. Attorney advertising. Prior results do not guarantee …
-
Arena Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Arena Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ARNA
13 Dec 2021 15:00 GMT
… investigating whether the sale of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) to Pfizer … behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee …
-
Hancock Horizon Burkenroad Small Cap Fund Buys Earthstone Energy Inc, Waitr Holdings Inc, OPKO Health Inc, Sells Arena Pharmaceuticals Inc, Digital Turbine Inc, Lamar Advertising Co
04 Sep 2021 11:26 GMT
-
Moderate to Severe Atopic Dermatitis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight
20 May 2025 17:00 GMT
New York, USA, May 20, 2025 (GLOBE NEWSWIRE) -- Moderate to Severe Atopic Dermatitis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight The moderate to severe atopic dermatitis market is experiencing strong growth driven by rising …
-
Arena Pharmaceuticals Inc (ARNA) Q4 2019 Earnings Call Transcript
27 Feb 2020 07:07 GMT
Image source: The Motley Fool.
Arena Pharmaceuticals Inc (NASDAQ:ARNA)
Q4 2019 … day, everyone, and welcome to Arena Pharmaceuticals Financial Results and Corporate Update … limited. Maybe they do some advertising, but that's generally …
-
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q4 2019 Results - Earnings Call Transcript
27 Feb 2020 06:22 GMT
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Q4 2019 … , everyone. And welcome to the Arena Pharmaceuticals’ Financial Results and Corporate Update … limited. Maybe they do some advertising but that’s generally about …
About
© 1995-2025